Finance

Beta
Lists
TNYA:NASDAQ
Tenaya Therapeutics Inc
$0.73
-5.70%
(-0.044) 1D
$0.74
+1.98% (+0.014)
After hours
Closed: Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TNYA...
Open
$0.76
High
$0.76
Low
$0.71
Mkt. cap
158.43M
Avg. vol.
4.66M
Volume
4.52M
52-wk high
$2.35
52-wk low
$0.53
EPS
-$0.47
Beta
2.82
Shares outstanding
217.00M
No. of employees
70
Open
$0.76
High
$0.76
Low
$0.71
Mkt. cap
158.43M
Avg. vol.
4.66M
Volume
4.52M
52-wk high
$2.35
52-wk low
$0.53
EPS
-$0.47
Beta
2.82
Shares outstanding
217.00M
No. of employees
70
Analyst outlook
Analyst Ratings
Based on 7 analysts giving stock ratings to TNYA in the past 3 months
Strong Buy
Buy
7
Hold
0
Sell
0
12 month forecast
Based on 7 Wall Street analysts offering 12 month price targets for TNYA in the last 3 months.
Highest
Current $0.73
$40.00 (+5,393.75%)
Average
$10.33 (+1,318.76%)
Lowest
$2.00 (+174.69%)
News stories
From sources across the web
About Tenaya Therapeutics Inc
CEO-
Employees70
Founded2016
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Last report
May 6, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.09 / -$0.09
-3.84%miss
Revenue / Est. (USD)
225.00K / 7.50M
-97.00%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
225.00K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
17.37M
15.36M
14.80M
14.84M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.71M
5.57M
5.98M
5.45M
Operating expense
24.08M
20.94M
20.78M
20.29M
Total operating expenses
24.08M
20.94M
20.78M
20.29M
Operating income
-24.08M
-20.94M
-20.78M
-20.06M
Other non operating income
-16.00K
3.00K
25.00K
-
EBT including unusual items
-23.28M
-20.28M
-20.18M
-19.27M
EBT excluding unusual items
-23.28M
-20.28M
-20.18M
-19.27M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-23.28M
-20.28M
-20.18M
-19.27M
Net profit margin
-
-
-
-8,565.33%
Earnings per share
-0.14
-0.12
-0.12
-0.09
Interest and investment income
815.00K
658.00K
575.00K
793.00K
Interest expense
-
-
-
-
Net interest expenses
815.00K
658.00K
575.00K
793.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-22.00M
-19.07M
-18.95M
-18.30M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more